Methamphetamine alone and in combination with fentanyl is associated with high mortality. Is there hope for people with methamphetamine use disorder? Currently there is no FDA approved medication, but there is contingency management and treatment options.
Thomas E. Freese, Ph.D., received his doctorate degree in clinical psychology from the California School of Professional Psychology in 1995. Dr. Freese is currently the Co-Director of UCLA Integrated Substance Abuse Programs and Co-Director of the SAMHSA-funded Pacific Southwest Addiction Technology Transfer Center (PSATTC, HHS Region 9). Dr. Freese has served as Principal Investigator on numerous projects funded by the California Department of Alcohol and Drug Programs and Department of Health Care Services to train providers in a variety of evidence-based substance use disorder treatment practices (including medications for addiction treatment, SBIRT, contingency management, and motivational interviewing). Dr. Freese has also led several large training and technical assistance projects that assist providers in implementing integrated treatment for co-occurring mental health and substance use disorders. He has been a featured presenter at conferences and meetings nationally and internationally on the impact and treatment of methamphetamine and opioid dependence. In addition, Dr. Freese has served as the Project Director on a number of studies including research on methamphetamine use. He has worked in the addiction field since 1983, and has developed and conducted trainings in 45 states and internationally, providing training and workshops for clinicians-in-training at the all levels.
